Abstract
Purpose. Tc-99m tetrofosmin launched for myocardial studies has recently also shown a good detectability for several tumors. Data on PNET imaging by Tc-99m tetrofosmin are not yet available.
Patient and method. In the case of a 21-year-old man suffering from pelvis PNET, Tc-99m tetrofosmin scintigraphy was performed additionally to CT and MRI.
Results. The gluteal and iliac tumor masses were visualized by Tc-99m tetrofosmin according to the CT and MRI results.
Discussion. Imaging with Tc-99m tetrofosmin could provide additional information to the available conventional radiological imaging modalities for diagnosis of PNET, and could be a useful tool for the restaging of the primary tumor.
Full Text
The Full Text of this article is available as a PDF (117.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fenlon H. M., Phelan N. C., O'Sullivan P., Tierney S., Gorey T., Ennis J. T. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology. 1997 Oct;205(1):214–220. doi: 10.1148/radiology.205.1.9314988. [DOI] [PubMed] [Google Scholar]
- Lind P., Gallowitsch H. J., Langsteger W., Kresnik E., Mikosch P., Gomez I. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med. 1997 Mar;38(3):348–352. [PubMed] [Google Scholar]
- Söderlund V., Jonsson C., Bauer H. C., Brosjö O., Jacobsson H. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med. 1997 May;38(5):682–686. [PubMed] [Google Scholar]